Table 1.
Effects sizes and efficacy per treatment and variable.
| Effects sizes1 | Fold changes relative to FLX2 | ||||
|---|---|---|---|---|---|
| Variables/treatments | FLX | PE | EE | PE | EE |
| Body weight | 0% | 8% | 45% | 8.0 | 45.0 |
| Locomotion | 2% | 15% | 44% | 7.5 | 22.0 |
| Sucrose intake | 25% | 58% | 63% | 2.3 | 2.5 |
| Sucrose preference | 0% | 20% | 50% | 20.0 | 50.0 |
| Immobility | 50% | 24% | 40% | 0.5 | 0.8 |
| Swimming | 41% | 33% | 40% | 0.8 | 1.0 |
| 5-HT | 69% | 0% | 49% | – | 0.7 |
| 5-HIAA | 25% | 0% | 35% | – | 1.4 |
| 5-HT turnover | 39% | 0% | 46% | – | 1.2 |
1Effect sizes corresponded to eta-squared coefficients expressed as percentages, which derived from planned comparisons between each treatment and SI. The grey-shaded numbers indicate the coefficients that were not significant. 2Fold changes were estimated with the eta-squared coefficients of PE and EE in comparison to those of FLX.